Disrupting the expression of key enzymes in cholesterol biosynthesis, such as HMGCR and SQLE, appears to prevent carcinogenesis mechanisms in colorectal, breast, prostate and NAFLD-HCC cancers [18–22]. The gene discussed is HMGCR; the disease is hepatocellular carcinoma.